MyAverix Finance
F · Healthcare
KRKA D.D. A NA (KN8)
Drug Manufacturers - Specialty & Generic
KRKA D.D. A NA (KN8) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $7.01B, P/E ratio is 17.10, net margin is 19.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for KN8
KRKA D.D. A NA (KN8) — FAQ
What is KRKA D.D. A NA's market cap?
KRKA D.D. A NA (KN8) has a reported market cap of $7.01B (data as of 2026-03-29).
What is KN8's P/E ratio?
The price-to-earnings (P/E) ratio for KRKA D.D. A NA (KN8) is 17.10 (data as of 2026-03-29).
Does KRKA D.D. A NA pay a dividend?
Dividend yield is not available in the current snapshot for KRKA D.D. A NA (KN8). Check the MyAverix Finance app for the latest dividend data.
What sector is KRKA D.D. A NA in?
KRKA D.D. A NA (KN8) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is KN8 listed on?
KN8 is listed on F.
What is KRKA D.D. A NA's net margin?
KRKA D.D. A NA (KN8) reports a net margin of 19.8% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.